Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 5,100 shares at $93.18 ($477K) on 2012-02-10, disclosed to the SEC on 2012-02-14.
Open-market sale of $477k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.18 | 2,000 | $186K | 39.1% |
| 2 | $93.18 | 2,100 | $196K | 41.0% |
| 3 | $94.75 | 1,000 | $95K | 19.9% |
| Total | $93.49 avg | 5,100 | $477K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |